go-v.orgcodex
Menu
Page tools

codex · Anatomy

ASP5736

Diagram for ASP5736
ASP5736 is an experimental drug developed by Astellas Pharma, which acts as a selective antagonist for the serotonin receptor 5-HT5A, with significantly higher potency than the older drug SB-699,551. In animal studies, it was found to reduce drug appropriate responding produced by LSD, but not DOI, · image: Wikimedia Commons

ASP5736 is an experimental drug developed by Astellas Pharma, which acts as a selective antagonist for the serotonin receptor 5-HT5A, with significantly higher potency than the older drug SB-699,551. In animal studies, it was found to reduce drug appropriate responding produced by LSD, but not DOI, and has also been found to reduce the cognitive dysfunction and memory deficits produced by scopolamine in animal studies, which has been suggested may indicate a potential role for 5-HT5A antagonists in the treatment of schizophrenia, as well as other conditions such as fragile X syndrome.

== See also == AS2674723

== References ==

Wikipedia contributors, "ASP5736", Wikipedia, revision 1370058432, retrieved 20 November 2026, source, CC BY-SA 4.0.

More Anatomy · Search the codex